The Latest Articles from Streetwise Reports


'An Insane Excessive Stock Market Bubble Today,' Current Overvaluation in the Market

  ()
In a Sept. 3, 2021 broadcast, two Crescat Capital representatives discussed the current macroeconomic environment. Portfolio Manager, Tavi Costa, highlighted the bearish part of the picture along with investment opportunities with bullish potential. Chief Investment Officer, Kevin Smith, presented evidence of an overvalued equity market and noted what that means for the precious metals sector. read more >

Leap Therapeutics Shares Skip Higher on Positive Preliminary Data From Gastric Cancer Study

  ()
Shares of Leap Therapeutics Inc. traded 38% higher after the company reported positive preliminary data from the Phase 2a DisTinGuish Study of DKN-01 plus tislelizumab at the ESMO Congress. read more >

Drill Results Demonstrate the 'Tremendous Gold Potential' of the Williams Brook Gold Project

  ()
Puma Exploration intersected 5.55 grams/tonne of gold over 50.15 meters starting at surface on its Williams Brook Gold Project. read more >

The Top Three Things Affecting the Rising Inflation Thesis

  ()
In a recent Crescat Capital briefing, Portfolio Manager Tavi Costa presented current financial metrics that are expected to affect the rising inflation thesis. Also, Chief Investment Officer Kevin Smith discussed his firm's view that the current market is creating an equity bubble and highlighted catalysts that could burst it. read more >

Echoes of the 1970s Haunt Modern Markets

Contributed Opinion
  ()
Sector expert Michael Ballanger explores how modern financial times mirror his formative years in the 1970s. read more >

French Biotech Firm Initiates Pivotal Phase 3 Study of Lanifibranor in 900 NASH Patients

Research Report
  ()
ROTH Capital Partners LLC advised in a research report that Inventiva S.A. has initiated enrollment in its highly anticipated pivotal Phase 3 Study of Lanifibranor in individuals diagnosed with nonalcoholic steatohepatitis. ROTH rates Inventiva a "Buy" with a 12-month price target of €55/share which represents a nearly four-fold increase over the current share price. read more >

Instil Bio Receives FDA Approval to Initiate Expanded Phase 2 Advanced Melanoma Study

  ()
Shares of Instil Bio Inc. traded 16% higher after the company reported it received IND clearance from the U.S. FDA to initiate a Phase 2 clinical trial in advanced melanoma patients. read more >

Lakewood Exploration: Silver Strand 43-101, Exploration, Adds Two Silver Projects in Nevada

Contributed Opinion
  ()
Joining us is Morgan Lekstrom, the CEO of Lakewood Exploration, which is on track to become the next pure silver play in the US. In this interview, Mr. Lekstrom discusses the latest update on the pending NI43-101 on the flagship Silver Strand, along with current exploration successes and new additions to the property bank, both in the prolific Hamilton District of Nevada, which are the Eliza Silver Project and Silverton Silver Mine, and we will conclude with pending catalysts. read more >

Two Analysts See Positives in E2 Gold's Hemlo-Like Project

  ()
"All the pieces are in place for a new bull market in gold to develop” for this small-cap gold exploration company with operations in Northern Ontario. read more >

Streetwise Live! Presents Heliostar Metals

  ()
Streetwise Live! Presents Heliostar Metals Ltd. Featuring Charles Funk, CEO and Director of Heliostar Metals Ltd., Adrian Day of Adrian Day Asset Management, and Joe Mazumdar, Editor/Analyst and Publisher of Exploration Insights. read more >

'Bona Fide Discovery' in Early Drilling at a Yukon Gold Project

  ()
In a recent broadcast, Geologic and Technical Director to Crescat Capital, Dr. Quinton Hennigh, provided updates on three exploration companies with recent news and covered seven other exploration stories of note. read more >

Biopharma Co. Posts Positive Objective Response & Disease Control Rates in Ovarian Cancer Studies

Research Report
  ()
H.C. Wainwright & Co. advised in a research report that updated data from Mersana Therapeutics Inc.'s expansion study supports its UPLIFT Study and will provide the basis for a new Phase 3 study in 2022. H.C. Wainwright rates Mersana a "Buy" with a target price of $28.00/share. read more >

FuelCell Energy Shares Charge Higher After Posting 43% Growth in Q3 Revenue

  ()
Shares of FuelCell Energy Inc. traded 15% higher after the company reported Q3/21 financial results highlighting positive YoY increases in revenue and gross margins driven by a 102% increase in revenues derived from licenses and service agreements. read more >

Streetwise Live! Presents E2Gold

  ()
Streetwise Live! Presents E2Gold Featuring Eric Owens, President, CEO and Director of E2Gold and Quinton Hennigh, PhD Geologic and Technical Director, Crescat Capital. read more >

aTyr Pharma's Fusion Protein Achieves Consistent Dose Response in Pulmonary Sarcoidosis Trial

  ()
Shares of aTyr Pharma Inc. traded 48% higher after the firm reported its ATYR1923 produced positive results in a Phase 1b/2a clinical study by demonstrating consistent favorable dose responses in pulmonary sarcoidosis patients. read more >

Company Will Direct Additional Exploration of Two Cornerstone Assets

  ()
Streetwise Reports spoke to Riley Gold Corp. CEO Todd Hilditch about how they will put “funds in the ground” following an oversubscribed private round. read more >

10 Reasons This Norwegian Industrial Investment Firm Is a Buy, Per Analyst

Research Report
  ()
"Aker's discounted pricing and stellar track record stand out as an attractive opportunity in the current market," a Pareto Securities report noted. read more >

Target Price Raised 24% on Top Picks in Oil E&P Space

  ()
"We think the still out of favor [oil] exploration and production sector offers a good risk/reward," a Pareto Securities report noted. read more >

Echo Global Receives $1.3 Billion Buyout Offer From NY Private Equity Firm

  ()
Echo Global Logistics Inc. shares traded 50% higher to a new 52-week high after the technology-enabled logistics company reported it entered into a definitive agreement to be acquired by The Jordan Company for $48.25 per share in cash. read more >

Alberta Junior Looks to Ride Higher With Steveville Helium Property

  ()
About 200 km east of Calgary in Canada’s prairies, a small exploration and production company has a plan to become a vertically integrated helium producer. It has the money, a proven helium-producing asset, and signed agreements with partners. Now it’s all about execution — and it’s off to a solid start. read more >

Explorer's Infill Drill Results Show Potential for Increasing Resource by 300% at Iberia Belt Property

Research Report
  ()
Clarus Securities Inc. advised in a research report that Emerita Resources Corp.'s recent infill drill results at its La Infanta Project in southern Spain demonstrate significant expansion potential. Clarus stated it is maintaining Emerita's "Speculative Buy" rating and 12-month price target of CA$4.50/share. read more >

Gevo and Chevron Partner to Invest in Manufacture of Sustainable Aviation Fuel

  ()
Shares of renewable fuels technology and development company Gevo Inc. traded 35% higher after the company reported it is teaming up with Chevron U.S.A. Inc. to invest in development and production of sustainable aviation fuel derived from inedible corn. read more >

Maiden Drill Results 'Rekindling the Fervor' at Explorer's Utah Gold Project

Research Report
  ()
A Haywood Securities report noted that "initial 2021 reverse circulation results highlight deep value in Liberty Gold's asset portfolio." read more >
News Update

Gold Explorer's Grab Sampling Extends Mineralized Corridor at Quebec Project From 60 Meters to 4.2 Kilometers

News Update
  ()
"At Quebec Precious Metals' Lloyd discovery area, results received from 2021 summer surface sampling program highlight several gold discoveries." read more >
News Update

Explorer Generates $600K From First Tranche of Private Placement

News Update
  ()
Cortus Metals plans to use the funds to continue exploring its Nevada properties. read more >
Showing Results: 1 to 25 of 601 Next

Get Our Streetwise Reports Newsletter Free and be the first to know!

A valid email address is required to subscribe

More Experts

"EMO reported the deepest intercept to date at La Infanta."
– Adam Schatzker, Research Capital Corporation
"Drilling makes CBR a compelling lever in a looming fall gold price boom."
– Brien Lundin, Gold Newsletter (Jefferson Financial)
"OMM is a compelling investment opportunity."
– Bill Newman, Research Capital Corporation